Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × trifluridine tipiracil drug combination × Clear all

NCT01904253 2024-09-05

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Phase 2 Terminated

Small Cell Lung Carcinoma